Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly
NCT ID: NCT04414319
Last Updated: 2023-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
170 participants
OBSERVATIONAL
2020-04-15
2023-04-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study
NCT04602260
Geriatric Care for Older People Hospitalised for COVID-19
NCT04947943
Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia
NCT04385797
Mortality, Gravity Predictive Factors and Clinical Evolution of Older COVID-19 Patients in Short Geriatric Services.
NCT05455892
Frailty and the Elderly in Martinique
NCT02871557
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In most diseases, older people have less typical symptomatology than that described for younger people. The investigators therefore hypothesize that within the framework of coronavirus disease 19, the clinical pictures in the elderly will present specificities that will need to be described. Moreover, since infection by the SARS-CoV-2 virus is new to humans, the investigators do not yet have sufficient information on the fate of the elderly, in terms of loss of autonomy, rehospitalization, institutionalization, mortality, etc. The investigators therefore assume that the clinical pictures in the elderly will present specificities that will need to be described. The investigators hypothesize that an acute infection of this type will have short-, medium-, and long-term repercussions in the elderly.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalized in a short stay or a rehabilitation geriatric wards at one of the participating centers;
* Positive by Reverse Transcriptase-Polymerase Chain Reaction for severe acute respiratory syndrome (SARS-CoV-2) coronavirus or be considered to have SARS-CoV-2 coronavirus based on lung CT data and physician opinion;
* Formal consent to answer the questionnaire or, in the event of inability to give consent, consent obtained from the trusted third party;
* Affiliation to a social security scheme.
Exclusion Criteria
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Center of Martinique
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Moustapha DRAME, PHD
Role: STUDY_DIRECTOR
Unversity hospital of Martinique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital of Rennes
Rennes, , France
Va de Lys-Ramsay Gds group Clinic
Tourcoing, , France
Hopsital of Valenciennes
Valenciennes, , France
University hospital of Guadeloupe
Les Abymes, , Guadeloupe
University hospital of Martinique
Fort-de-France, , Martinique
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20_RIPH3-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.